MERKEL, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.838
AS - Asia 4.330
EU - Europa 3.156
SA - Sud America 697
AF - Africa 128
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
AN - Antartide 1
Totale 27.174
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.753
SG - Singapore 1.795
HK - Hong Kong 1.041
CN - Cina 1.032
BR - Brasile 648
FI - Finlandia 568
DE - Germania 439
IT - Italia 433
PL - Polonia 359
SE - Svezia 312
FR - Francia 269
UA - Ucraina 244
VN - Vietnam 193
RU - Federazione Russa 169
GB - Regno Unito 168
TR - Turchia 53
IN - India 51
NL - Olanda 46
IE - Irlanda 42
CA - Canada 36
IQ - Iraq 21
ZA - Sudafrica 20
GR - Grecia 19
BD - Bangladesh 18
AT - Austria 14
MX - Messico 13
AR - Argentina 12
PK - Pakistan 11
VE - Venezuela 11
EG - Egitto 10
JP - Giappone 10
JO - Giordania 9
MA - Marocco 9
TH - Thailandia 9
CI - Costa d'Avorio 8
EC - Ecuador 8
KE - Kenya 8
RO - Romania 8
UZ - Uzbekistan 8
AZ - Azerbaigian 7
BG - Bulgaria 6
CO - Colombia 6
CZ - Repubblica Ceca 6
ES - Italia 6
EU - Europa 6
ID - Indonesia 6
LB - Libano 6
PT - Portogallo 6
SA - Arabia Saudita 6
AL - Albania 5
AU - Australia 5
CV - Capo Verde 5
DK - Danimarca 5
DZ - Algeria 5
ET - Etiopia 5
IL - Israele 5
LY - Libia 5
MY - Malesia 5
NP - Nepal 5
SI - Slovenia 5
SN - Senegal 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
BB - Barbados 4
GA - Gabon 4
NZ - Nuova Zelanda 4
PE - Perù 4
TN - Tunisia 4
AF - Afghanistan, Repubblica islamica di 3
AM - Armenia 3
BY - Bielorussia 3
CG - Congo 3
GE - Georgia 3
JM - Giamaica 3
KG - Kirghizistan 3
KR - Corea 3
LV - Lettonia 3
NI - Nicaragua 3
NO - Norvegia 3
PA - Panama 3
PG - Papua Nuova Guinea 3
PR - Porto Rico 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
AD - Andorra 2
AO - Angola 2
BE - Belgio 2
BF - Burkina Faso 2
BN - Brunei Darussalam 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
DM - Dominica 2
GN - Guinea 2
HT - Haiti 2
IR - Iran 2
KY - Cayman, isole 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
Totale 27.108
Salva come PNG Salva come JPEG
Città #
Fairfield 2.610
Woodbridge 1.857
Houston 1.644
Ann Arbor 1.410
Chandler 1.343
Jacksonville 1.133
Ashburn 1.104
Wilmington 1.068
Hong Kong 1.040
Seattle 938
Singapore 896
Cambridge 889
Boardman 537
Princeton 531
Santa Clara 408
Bytom 356
Medford 287
San Diego 260
Nanjing 224
Dong Ket 180
Beijing 177
Helsinki 177
Des Moines 164
Roxbury 148
Guangzhou 90
Norwalk 75
Shenyang 73
Hebei 72
Padova 69
Nanchang 66
Changsha 57
Munich 56
Jiaxing 50
Dublin 41
São Paulo 40
Tianjin 32
Yenibosna 32
London 31
Rome 30
New York 29
Redwood City 27
Kharkiv 25
Chicago 19
Falkenstein 19
Los Angeles 19
Belo Horizonte 18
Jinan 18
Rio de Janeiro 14
Brasília 13
Dearborn 12
Ogden 12
Porto Alegre 12
Dallas 11
Sorocaba 11
Ankara 10
Campinas 10
Curitiba 10
Kunming 10
Ottawa 10
Amman 9
Amsterdam 9
Baghdad 9
Borås 9
Hounslow 9
Milan 9
Recife 9
Zhengzhou 9
Abidjan 8
Boston 8
Cape Town 8
Falls Church 8
Ho Chi Minh City 8
Las Vegas 8
Nairobi 8
San Francisco 8
Vienna 8
Atlanta 7
Baku 7
Genoa 7
Nuremberg 7
Tashkent 7
Turku 7
Venice 7
Washington 7
Bologna 6
Brooklyn 6
Florence 6
Goiânia 6
Hangzhou 6
Johannesburg 6
Juiz de Fora 6
Kilburn 6
Ningbo 6
Paris 6
Praia Grande 6
Rockville 6
Salvador 6
Taizhou 6
Tokyo 6
Toronto 6
Totale 20.800
Salva come PNG Salva come JPEG
Nome #
The animal naming test: An easy tool for the assessment of hepatic encephalopathy 210
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats. 162
The self-morningness/eveningness (Self-ME): An extremely concise and totally subjective assessment of diurnal preference 158
Acute liver rejection: Accuracy and predictive values of Doppler US measurements - Initial experience 156
A SIMPLIFIED PSYCHOMETRIC EVALUATION FOR THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY 154
Interobserver and inter-equipment variability of echo-Doppler sonographic evaluation of the superior mesenteric artery. 149
Clinical value of asterixis in 374 well-characterised patients with cirrhosis and varying degree of hepatic encephalopathy 142
Training of Italian emergency medicine residents in prehospital emergency medicine:state of the art and perspectives of improvement 140
Ammonia-related changes in cerebral electrogenesis in healthy subjects and patients with cirrhosis. 139
A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis 138
Nutrition and survival in patients with liver cirrhosis 137
Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size 136
Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis. 133
New abdominal collaterals at ultrasound: A clue of progression of portal hypertension 131
Blood flow of experimental liver metastases in rat as evaluated by the locally injected 133-Xenon washout. 130
Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes! 129
Beta-blockers in the prevention of aggravation of esophageal varices in patients with cirrhosis and small varices: a placebo-controlled clinical trial. 128
Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension 128
Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. 127
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis 127
Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites 127
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 127
Electroencephalography in patients with cirrhosis. 126
Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria 124
EVALUATION OF SPLANCHNIC ANGIOGRAPHY AS A PROGNOSTIC INDEX OF SURVIVAL IN PATIENTS WITH CIRRHOSIS 124
Incidence and natural history of small esophageal varices in cirrhotic patients 121
Encephalopathy or hepatic encephalopathy? 121
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats 119
Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters 119
Cost-effectiveness analysis of beta-blockers vs endoscopic surveillance in patients with cirrhosis and small varices 116
Visual attention in cirrhotic patients: a study on covert visual attention orienting. 115
The Influence of Environmental Factors on Sleep Quality in Hospitalized Medical Patients 115
Hepatitis C virus reinfection in liver transplant patients: evaluation of liver damage progression with echo-color doppler. 115
Theophylline pharmacokinetics and liver function indexes in chronic liver disease. 114
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 113
Renal water and sodium handling in compensated liver cirrhosis: mechanism of the impaired natriuresis after saline loading. 113
Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow. 112
Hepatitis C Virus Reinfection in Liver Transplant Patients: Evaluation of Liver Damage Progression with Echo-Color Doppler 112
Effects of chronic therapy with nadolol on portal hemodynamics and on splanchnic impedance indices using Doppler sonography: Comparison between acute and chronic effects 111
Renal haemodynamics in essential hypertension assessed by 133-Xenon washout and selective renal angiography 111
Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis. 111
Renal effects of nadolol in cirrhosis. 111
Portal hypertension and portal hypertensive gastropathy in patients with liver cirrhosis: a haemodynamic study 111
Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost 110
Metabolic control of kidney hemodynamics in normal and insulin-dependent diabetic subjects. Effects of acetoacetic, lactic, and acetic acids. 110
Interobserver and inter-equipment variability of echo-Doppler evaluation of the superior mesenteric artery. 109
Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension. 109
Simple tools for complex syndromes: A three-level difficulty test for hepatic encephalopathy 109
Accuracy and predictive value of echo-Doppler measurements in acute liver rejection -- initial experience 108
A short cut to predict the clinical response to beta-blocker therapy in cirrhosis? 108
Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial. 108
Prognostic benefit of the addition of an electroencephalographic (EEG) index to the MELD score: the MELD-EEG. 108
Prognostic Benefit of the Addition of a Quantitative Index of Hepatic Encephalopathy to the MELD score: the MELD-EEG 108
HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients 107
Carbon monoxide-mediated activation of a large-conductance calcium-activated potassium channels contrinutes to mesenteric vasodilation in cirrhotic rats. 321 : 187-194. 106
Carbon monoxide-mediated activation of large-conductance calcium-activated potassium channels contributes to mesenteric vasodilatation in cirrhotic rats with ascites 106
Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension 105
Il timing del trapianto di fegato: Child-Pugh o Mayo score? 105
Long-term effects of beta-adrenergic blockade with nadolol on hepatic and renal haemodynamics and function in cirrhotics. 105
Heme oxygenase regulates the response of intrarenal arteries to alpha-adrenergic stimulation in experimental cirrhosis. 104
Natural History of cirrhotic patients with small esophageal varices: a prospective study 103
Confounders in the detection of minimal hepatic encephalopathy: a neuropsychological and quantified EEG study. 103
Bright times for patients with cirrhosis and delayed sleep habits: a case report of the beneficial effect of light therapy 102
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. 101
Sleep-wake abnormalities in patients with cirrhosis. 101
AISF practice guidelines for portal hypertension.Committee for portal hypertension of the Italian Association for the Study of the Liver. 100
A COST-EFFECTIVENESS ANALYSIS OF PROPHYLAXIS OF VARICEAL BLEEDING STARTING FROM SMALL ESOPHAGEAL VARICES COMPARED TO SURVEILLANCE AND TREATMENT STARTING FROM LARGE ONES 100
Hemodynamic and clinical evaluation of nadolol in the treatment of portal hypertension in patients with cirrhosis. 100
IgM-linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease 99
Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates 99
Endotoxins and the hepatorenal syndrome. 99
PLASMA CARNITINE LEVELS IN LIVER-CIRRHOSIS - RELATIONSHIP WITH NUTRITIONAL-STATUS AND LIVER-DAMAGE 98
Attention: Minimal hepatic encephalopathy and road accidents 98
Intrarenal blood flow, circulation time, and cortical vascular volume in patients with cirrhosis. 98
Hemodynamic and clinical evaluation of nadolol in the treatment of portal hypertension in patients with cirrhosis. 97
Agreement and predictive validity of neurophysiological, psychometric, and psychophysical indices of hepatic encephalopathy. 97
Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis 96
Optimizing the time-frame for the definition of bleeding-related death after acute variceal bleeding in cirrhosis 96
Porcine and human insulin absorption from subcutaneous tissues in normal and insulin dependent diabetic subjects: a deconvolution-based approach 96
Prevention of the formation and growth of esophageal varices 96
Vascularization of experimental liver metastases. 2 - Blood flow. 95
Validation of a predictive model for chronic renal dysfunction following liver transplantation. 95
Cirrhosis and muscle cramps: evidence of a causal relationship. 94
The cirrhotic patient with no varices and with small varices 94
Nutritional and prognostic significance of serum hypothyroxinemia in hospitalized patients with liver cirrhosis 94
Covert hepatic encephalopathy: Agreement and predictive validity of different indices 94
Short-term effects of transcatheter arterial chemoembolisation on metabolic activity of the liver of cirrhotic patients with hepatocellular carcinoma 94
The use of human albumin millimicrospheres tagged with 99mTc in the evaluation of the removal capacity of the reticuloendothelial system. 93
Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis. 93
Primary Prophylaxis of Bleeding from Esophageal Varices in Cirrhosis 93
Lowering portal pressure improves outcomes of patients with cirrhosis, with or without ascites: a meta-analysis. 93
Value of prealbumin plasma levels as liver test. 92
Malnutrition in alcoholic and virus-related cirrhosis 92
Effect of nadolol on liver haemodynamics and function in patients with cirrhosis. 92
Evaluation of renal tubular damage in liver cirrhosis by urinary enzymes and beta-2-microglobulin excretions. 91
Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients 91
Proteinuria in patients with cirrhosis: relationship between renal and hepatic function. 90
Splenic Doppler impedance indices: influence of different portal hemodynamic conditions. 90
Prognostic indicators of risk for first variceal bleeding in cirrhosis: A multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) Index 90
Cost-effective analysis of primary prophylaxis of variceal bleeding with beta-blockers vs. endoscopic surveillance in cirrhotic patients with small esophageal varices. 89
Totale 11.195
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.229
article - articoli 75.155
book - libri 874
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.358
Totale 177.616
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.593 123 212 60 195 103 255 71 272 394 253 319 336
2021/20223.553 56 577 371 212 188 169 135 354 207 52 346 886
2022/20232.937 699 244 79 281 495 436 3 186 344 18 112 40
2023/20241.093 63 205 102 85 58 58 33 33 45 23 191 197
2024/20256.412 9 481 323 261 1.009 118 245 411 602 239 1.086 1.628
2025/202652 52 0 0 0 0 0 0 0 0 0 0 0
Totale 27.254